Home › Cancro al fegato (carcinoma epatocellulare) › Maryland › Baltimore
Studi clinici su Cancro al fegato (carcinoma epatocellulare) a Baltimore, MD
11 studi su Cancro al fegato (carcinoma epatocellulare) cercano partecipanti presso sedi a Baltimore e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #14, Baltimore
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
In reclutamentoFase 1/2
- Research Facility, Baltimore
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
In reclutamentoFase 1
- John Hopkins University, Baltimore
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
In reclutamentoStudio osservazionale
- Johns Hopkins Hospital, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
In reclutamentoFase 1/2
- Research Site, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- The John Hopkins Hospital, Baltimore
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
In reclutamento
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
In reclutamentoFase 1/2
- The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
In reclutamentoFase 2
- University of Maryland Medical Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · a 8 mi di distanza
Studi su Cancro al fegato (carcinoma epatocellulare) in altre città
- Houston, TX31 studi
- New York City, NY24 studi
- Dallas, TX19 studi
- Los Angeles, CA19 studi
- Boston, MA18 studi
- Cleveland, OH18 studi
- Chicago, IL16 studi
- Philadelphia, PA16 studi
- Pittsburgh, PA15 studi
- San Francisco, CA14 studi
- Orange, CA14 studi
- Jacksonville, FL14 studi
Altri studi a Baltimore
- Cancro del polmone non a piccole cellule60 studi
- Cancro al seno47 studi
- Cancro alla prostata43 studi
- Cancro ai polmoni40 studi
- Cancro (tutti i tipi)37 studi
- Cancro pancreatico31 studi
- Cancro colorettale31 studi
- Cancro metastatico28 studi
- Obesità26 studi
- Cancro della vescica24 studi
- Insufficienza cardiaca24 studi
- Cancro ovarico22 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.